HEADER IMMUNE SYSTEM, MEMBRANE PROTEIN 26-APR-05 1ZHN TITLE CRYSTAL STRUCTURE OF MOUSE CD1D BOUND TO THE SELF LIGAND TITLE 2 PHOSPHATIDYLCHOLINE CAVEAT 1ZHN NAG C 1 HAS WRONG CHIRALITY AT ATOM C1 MAN D 3 HAS WRONG CAVEAT 2 1ZHN CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CD1D1 ANTIGEN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: T-CELL SURFACE GLYCOPROTEIN CD1D1; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: SELF PHOSPHOLIPID COPURIFIED WITH PROTEIN; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 EXPRESSION_SYSTEM: DROSOPHILA MELANOGASTER; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FRUIT FLY; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7227; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: S2 CELLS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PRMHA-3; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 12 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 13 ORGANISM_TAXID: 10090; SOURCE 14 EXPRESSION_SYSTEM: DROSOPHILA MELANOGASTER; SOURCE 15 EXPRESSION_SYSTEM_COMMON: FRUIT FLY; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 7227; SOURCE 17 EXPRESSION_SYSTEM_CELL_LINE: S2 CELLS; SOURCE 18 EXPRESSION_SYSTEM_VECTOR: PRMHA-3 KEYWDS MHC FOLD; ANTIGEN BINDING DOMAIN; IG FOLD, IMMUNE SYSTEM, MEMBRANE KEYWDS 2 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR B.GIABBAI,S.SIDOBRE,M.M.D.CRISPIN,Y.SANCHEZ RUIZ,A.BACHI, AUTHOR 2 M.KRONENBERG,I.A.WILSON,M.DEGANO REVDAT 5 23-AUG-23 1ZHN 1 HETSYN REVDAT 4 29-JUL-20 1ZHN 1 CAVEAT COMPND REMARK HETNAM REVDAT 4 2 1 LINK SITE ATOM REVDAT 3 13-JUL-11 1ZHN 1 VERSN REVDAT 2 24-FEB-09 1ZHN 1 VERSN REVDAT 1 19-JUL-05 1ZHN 0 JRNL AUTH B.GIABBAI,S.SIDOBRE,M.M.D.CRISPIN,Y.SANCHEZ RUIZ,A.BACHI, JRNL AUTH 2 M.KRONENBERG,I.A.WILSON,M.DEGANO JRNL TITL CRYSTAL STRUCTURE OF MOUSE CD1D BOUND TO THE SELF LIGAND JRNL TITL 2 PHOSPHATIDYLCHOLINE: A MOLECULAR BASIS FOR NKT CELL JRNL TITL 3 ACTIVATION JRNL REF J.IMMUNOL. V. 175 977 2005 JRNL REFN ISSN 0022-1767 JRNL PMID 16002697 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH Z.ZENG,A.R.CASTANO,B.W.SEGELKE,E.A.STURA,P.A.PETERSON, REMARK 1 AUTH 2 I.A.WILSON REMARK 1 TITL CRYSTAL STRUCTURE OF MOUSE CD1: AN MHC-LIKE FOLD WITH A REMARK 1 TITL 2 LARGE HYDROPHOBIC BINDING GROOVE REMARK 1 REF SCIENCE V. 277 339 1997 REMARK 1 REFN ISSN 0036-8075 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 76.70 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 3 NUMBER OF REFLECTIONS : 11481 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.222 REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.281 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1018 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87 REMARK 3 REFLECTION IN BIN (WORKING SET) : 792 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.57 REMARK 3 BIN R VALUE (WORKING SET) : 0.3020 REMARK 3 BIN FREE R VALUE SET COUNT : 71 REMARK 3 BIN FREE R VALUE : 0.3850 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2987 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 170 REMARK 3 SOLVENT ATOMS : 50 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.72 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.34000 REMARK 3 B22 (A**2) : -1.16000 REMARK 3 B33 (A**2) : 2.50000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.430 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.309 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 16.190 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.896 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.838 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3255 ; 0.005 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 2836 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4423 ; 1.473 ; 1.971 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6614 ; 0.766 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 366 ; 7.160 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 146 ;35.718 ;24.178 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 514 ;18.958 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 15 ;23.189 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 481 ; 0.078 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3423 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 629 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 687 ; 0.209 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3012 ; 0.186 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1537 ; 0.189 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 2029 ; 0.089 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 86 ; 0.178 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 10 ; 0.110 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 42 ; 0.204 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 5 ; 0.170 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2385 ; 0.688 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 742 ; 0.067 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2989 ; 0.773 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1665 ; 0.957 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1434 ; 1.722 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 1ZHN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-MAY-05. REMARK 100 THE DEPOSITION ID IS D_1000032734. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-MAY-98 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL7-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA, CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12734 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 76.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05600 REMARK 200 FOR THE DATA SET : 8.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.29000 REMARK 200 FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1CD1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS, 200 MM NH4(SO4)2, 25% PEG REMARK 280 4000, PH 7.4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.89900 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.03000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 53.45450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 55.03000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.89900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 53.45450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A HETERODIMERIC CD1D/BETA- REMARK 300 2MICROGLOBULIN COMPLEX BOUND TO ONE PC MOLECULE, AS FOUND IN THE REMARK 300 CRYSTAL ASYMMETRIC UNIT REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7160 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19160 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 93 REMARK 465 TYR A 94 REMARK 465 PRO A 95 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 289 O HOH A 293 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 34 CB - CG - OD2 ANGL. DEV. = 6.0 DEGREES REMARK 500 ASP B 98 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 20 -145.81 -127.54 REMARK 500 SER A 89 -144.53 47.70 REMARK 500 LYS A 91 107.58 178.84 REMARK 500 LEU A 116 115.23 -161.54 REMARK 500 VAL A 125 -36.81 -130.99 REMARK 500 ASP A 166 -66.49 -105.64 REMARK 500 HIS B 31 136.46 -175.41 REMARK 500 LYS B 48 30.49 -95.30 REMARK 500 TRP B 60 -15.88 72.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 SER A 89 PRO A 90 145.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1CD1 RELATED DB: PDB REMARK 900 MOUSE CD1D WITH NO LIGAND REMARK 900 RELATED ID: 1GZP RELATED DB: PDB REMARK 900 HUMAN CD1B BOUND TO PI REMARK 900 RELATED ID: 1GZQ RELATED DB: PDB REMARK 900 HUMAN CD1B BOUND TO GM1 REMARK 900 RELATED ID: 1ONQ RELATED DB: PDB REMARK 900 HUMAN CD1A BOUND TO SULFATIDE SELF LIGAND DBREF 1ZHN A 7 279 GB 12832671 BAB22206 25 297 DBREF 1ZHN B 1 99 UNP P01887 B2MG_MOUSE 21 119 SEQRES 1 A 273 ASN TYR THR PHE ARG CYS LEU GLN MET SER SER PHE ALA SEQRES 2 A 273 ASN ARG SER TRP SER ARG THR ASP SER VAL VAL TRP LEU SEQRES 3 A 273 GLY ASP LEU GLN THR HIS ARG TRP SER ASN ASP SER ALA SEQRES 4 A 273 THR ILE SER PHE THR LYS PRO TRP SER GLN GLY LYS LEU SEQRES 5 A 273 SER ASN GLN GLN TRP GLU LYS LEU GLN HIS MET PHE GLN SEQRES 6 A 273 VAL TYR ARG VAL SER PHE THR ARG ASP ILE GLN GLU LEU SEQRES 7 A 273 VAL LYS MET MET SER PRO LYS GLU ASP TYR PRO ILE GLU SEQRES 8 A 273 ILE GLN LEU SER ALA GLY CYS GLU MET TYR PRO GLY ASN SEQRES 9 A 273 ALA SER GLU SER PHE LEU HIS VAL ALA PHE GLN GLY LYS SEQRES 10 A 273 TYR VAL VAL ARG PHE TRP GLY THR SER TRP GLN THR VAL SEQRES 11 A 273 PRO GLY ALA PRO SER TRP LEU ASP LEU PRO ILE LYS VAL SEQRES 12 A 273 LEU ASN ALA ASP GLN GLY THR SER ALA THR VAL GLN MET SEQRES 13 A 273 LEU LEU ASN ASP THR CYS PRO LEU PHE VAL ARG GLY LEU SEQRES 14 A 273 LEU GLU ALA GLY LYS SER ASP LEU GLU LYS GLN GLU LYS SEQRES 15 A 273 PRO VAL ALA TRP LEU SER SER VAL PRO SER SER ALA HIS SEQRES 16 A 273 GLY HIS ARG GLN LEU VAL CYS HIS VAL SER GLY PHE TYR SEQRES 17 A 273 PRO LYS PRO VAL TRP VAL MET TRP MET ARG GLY ASP GLN SEQRES 18 A 273 GLU GLN GLN GLY THR HIS ARG GLY ASP PHE LEU PRO ASN SEQRES 19 A 273 ALA ASP GLU THR TRP TYR LEU GLN ALA THR LEU ASP VAL SEQRES 20 A 273 GLU ALA GLY GLU GLU ALA GLY LEU ALA CYS ARG VAL LYS SEQRES 21 A 273 HIS SER SER LEU GLY GLY GLN ASP ILE ILE LEU TYR TRP SEQRES 1 B 99 ILE GLN LYS THR PRO GLN ILE GLN VAL TYR SER ARG HIS SEQRES 2 B 99 PRO PRO GLU ASN GLY LYS PRO ASN ILE LEU ASN CYS TYR SEQRES 3 B 99 VAL THR GLN PHE HIS PRO PRO HIS ILE GLU ILE GLN MET SEQRES 4 B 99 LEU LYS ASN GLY LYS LYS ILE PRO LYS VAL GLU MET SER SEQRES 5 B 99 ASP MET SER PHE SER LYS ASP TRP SER PHE TYR ILE LEU SEQRES 6 B 99 ALA HIS THR GLU PHE THR PRO THR GLU THR ASP THR TYR SEQRES 7 B 99 ALA CYS ARG VAL LYS HIS ASP SER MET ALA GLU PRO LYS SEQRES 8 B 99 THR VAL TYR TRP ASP ARG ASP MET MODRES 1ZHN ASN A 20 ASN GLYCOSYLATION SITE MODRES 1ZHN ASN A 42 ASN GLYCOSYLATION SITE MODRES 1ZHN ASN A 165 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET FUC C 2 10 HET NAG D 1 14 HET NAG D 2 14 HET MAN D 3 11 HET MAN D 4 11 HET MAN D 5 11 HET FUC D 6 10 HET NAG A 2 14 HET PC6 A 1 55 HET GOL B2002 6 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM PC6 7-[(DODECANOYLOXY)METHYL]-4-HYDROXY-N,N,N-TRIMETHYL-9- HETNAM 2 PC6 OXO-3,5,8-TRIOXA-4-PHOSPHADOTRIACONTAN-1-AMINIUM 4- HETNAM 3 PC6 OXIDE HETNAM GOL GLYCEROL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 NAG 4(C8 H15 N O6) FORMUL 3 FUC 2(C6 H12 O5) FORMUL 4 MAN 3(C6 H12 O6) FORMUL 6 PC6 C45 H90 N O8 P FORMUL 7 GOL C3 H8 O3 FORMUL 8 HOH *50(H2 O) HELIX 1 1 SER A 59 MET A 87 1 29 HELIX 2 2 PRO A 140 TRP A 142 5 3 HELIX 3 3 LEU A 143 ASP A 153 1 11 HELIX 4 4 ASP A 153 ASP A 166 1 14 HELIX 5 5 ASP A 166 GLY A 179 1 14 HELIX 6 6 GLY A 179 GLU A 184 1 6 HELIX 7 7 HIS A 267 GLY A 271 5 5 SHEET 1 A 8 SER A 48 PHE A 49 0 SHEET 2 A 8 LEU A 35 TRP A 40 -1 N ARG A 39 O SER A 48 SHEET 3 A 8 SER A 24 LEU A 32 -1 N LEU A 32 O LEU A 35 SHEET 4 A 8 TYR A 8 PHE A 18 -1 N SER A 17 O ARG A 25 SHEET 5 A 8 GLU A 97 TYR A 107 -1 O ALA A 102 N CYS A 12 SHEET 6 A 8 ALA A 111 PHE A 120 -1 O PHE A 115 N GLY A 103 SHEET 7 A 8 LYS A 123 TRP A 129 -1 O VAL A 126 N VAL A 118 SHEET 8 A 8 SER A 132 THR A 135 -1 O SER A 132 N TRP A 129 SHEET 1 B 4 VAL A 190 PRO A 197 0 SHEET 2 B 4 HIS A 203 PHE A 213 -1 O VAL A 207 N SER A 194 SHEET 3 B 4 TRP A 245 GLU A 254 -1 O VAL A 253 N ARG A 204 SHEET 4 B 4 HIS A 233 ARG A 234 -1 N HIS A 233 O THR A 250 SHEET 1 C 4 VAL A 190 PRO A 197 0 SHEET 2 C 4 HIS A 203 PHE A 213 -1 O VAL A 207 N SER A 194 SHEET 3 C 4 TRP A 245 GLU A 254 -1 O VAL A 253 N ARG A 204 SHEET 4 C 4 LEU A 238 PRO A 239 -1 N LEU A 238 O TYR A 246 SHEET 1 D 4 GLN A 227 GLU A 228 0 SHEET 2 D 4 TRP A 219 ARG A 224 -1 N ARG A 224 O GLN A 227 SHEET 3 D 4 LEU A 261 LYS A 266 -1 O ALA A 262 N MET A 223 SHEET 4 D 4 ILE A 275 TYR A 278 -1 O ILE A 275 N VAL A 265 SHEET 1 E 4 GLN B 6 SER B 11 0 SHEET 2 E 4 ASN B 21 PHE B 30 -1 O TYR B 26 N GLN B 8 SHEET 3 E 4 PHE B 62 PHE B 70 -1 O ALA B 66 N CYS B 25 SHEET 4 E 4 GLU B 50 MET B 51 -1 N GLU B 50 O HIS B 67 SHEET 1 F 4 GLN B 6 SER B 11 0 SHEET 2 F 4 ASN B 21 PHE B 30 -1 O TYR B 26 N GLN B 8 SHEET 3 F 4 PHE B 62 PHE B 70 -1 O ALA B 66 N CYS B 25 SHEET 4 F 4 SER B 55 PHE B 56 -1 N SER B 55 O TYR B 63 SHEET 1 G 4 LYS B 44 LYS B 45 0 SHEET 2 G 4 GLU B 36 LYS B 41 -1 N LYS B 41 O LYS B 44 SHEET 3 G 4 TYR B 78 LYS B 83 -1 O ARG B 81 N GLN B 38 SHEET 4 G 4 LYS B 91 TYR B 94 -1 O LYS B 91 N VAL B 82 SSBOND 1 CYS A 104 CYS A 168 1555 1555 2.04 SSBOND 2 CYS A 208 CYS A 263 1555 1555 2.03 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.03 LINK C1 NAG A 2 ND2 ASN A 42 1555 1555 1.45 LINK ND2 ASN A 20 C1 NAG C 1 1555 1555 1.45 LINK ND2 ASN A 165 C1 NAG D 1 1555 1555 1.44 LINK O6 NAG C 1 C1 FUC C 2 1555 1555 1.45 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.44 LINK O6 NAG D 1 C1 FUC D 6 1555 1555 1.45 LINK O4 NAG D 2 C1 MAN D 3 1555 1555 1.45 LINK O3 MAN D 3 C1 MAN D 4 1555 1555 1.44 LINK O6 MAN D 3 C1 MAN D 5 1555 1555 1.45 CISPEP 1 TYR A 214 PRO A 215 0 -1.45 CISPEP 2 HIS B 31 PRO B 32 0 5.13 CRYST1 41.798 106.909 110.060 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023925 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009354 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009086 0.00000